Overview
DeepHealth provides AI-powered medical imaging and health informatics solutions that help radiologists analyze X-rays, CTs, and MRIs by automating parts of image interpretation, highlighting areas of concern, and delivering quantitative insights. It works by integrating AI into radiology workflows via cloud-based software, enabling automated image analysis, scoring, and reporting within enterprise imaging systems. The company differentiates itself through its integration with RadNet and strategic acquisitions of iCAD and CIMAR UK, expanding breast imaging capabilities, interoperability, and the scale of its deployments. Its goal is to accelerate the adoption of AI in real-world healthcare, improve diagnostic accuracy and consistency, and streamline imaging workflows across hospitals and health systems.
Work here?Claim your company
Simplify's take
What believers are saying
- DeepHealth launched Reporting Pro commercially on June 10, 2026, with external customers contracting.
- ECR 2026 data showed AI reduced interpretation time and scan slot time by up to 30%.
- October 8, 2026 prostate data showed 18.9% fewer biopsies at 98.4% sensitivity.
What critics are saying
- Radiology Partners and Mosaic Clinical Technologies now compete directly with DeepHealth’s AI and teleradiology stack.
- DeepHealth’s external revenue depends on RadNet’s buy-build strategy and hospital adoption cycles through 2027.
- If reimbursement stalls or rivals bundle AI cheaper, DeepHealth becomes a feature, not a company.
What makes DeepHealth unique
- RadNet’s 439-center network gives DeepHealth real-world deployment data competitors lack.
- Reporting Pro unifies speech, AI findings, measurements, impressions, QA, and structured reporting.
- Gleamer plus iCAD broaden DeepHealth across breast, chest, prostate, and multimodality workflows.
Help us improve and share your feedback! Did you find this helpful?